Healthcare - Biotechnology - NASDAQ - US
$ 36.45
-0.274 %
$ 2.71 B
Market Cap
-7.81
P/E
Price Target
Average
104.12%
Revenue Forecast
Estimate
221.81%
EBIT
Estimate
23.60%
Net Income
Estimate
34.64%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
SpringWorks Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for SWTX of $74.4 , with forecasts ranging from a low of $50 to a high of $94 .
SWTX Lowest Price Target
Wall Street Target
50 USD
37.17%
SWTX Average Price Target
Wall Street Target
74.4 USD
104.12%
SWTX Highest Price Target
Wall Street Target
94 USD
157.89%
REVENUE FORECAST
Revenue Forecast Chart SWTX
EBIT FORECAST
EBIT Forecast Chart SWTX
NET INCOME FORECAST
Net Income Chart SWTX